Tofacitinib Citrate

Company Tracker: Pfizer turns to acquisitions as Covid products’ sales nosedive

Over the last five years, a lot has changed for Pfizer Inc, one of the world’s leading pharma

DMF submissions rise 12.1% in 2022; India sees 10.6% drop in Type II filings

In 2022, the world finally began to emerge out of Covid-related restrictions. Though 2020 and 2021

DMF submissions in 2021: India, China continue to top filings

The year 2021 was eclipsed by the Covid-19 pandemic. In our update for the first half of 2020, we h

Top drugs and pharmaceutical companies of 2019 by revenues

Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-

FDA’s 2016 Approvals of New Drugs, Formulations, Strengths & More

After 2 years of sky-high approval numbers, the US Food and Drug Administration’s (FDA) Center

US DMF filings indicate a robust API industry, with multiple first-to-file challenges

This week, PharmaCompass brings you a compilation of the Drug Master Files (DMFs) updates at

Generic challenges, the next first-to-files, GDUFA dues (FY 2016) and more

PharmaCompass has assessed the second quarter US Drug Master File (DMFs) filings. In our view, with

Who has the biggest one? Sales of the top pharma products by revenue.

We always knew math was fuzzy, but never imagined addition could get so complicated.  A recent